Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study - India's first trial for a novel autologous BCMA directed CAR-T cell therapy in

By: business-standard.com

Oct 08 2024
0
0 Views

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Related

Maruti Suzuki launches Grand Vitara Dominion Limited Edition

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Crisil expects 25% hit on discount brokers' PBT due to regulatory changes

Discount brokers to be impacted most by new F&O regulations: CRISIL

Torrent Power receives LoA from MSEDCL

Sterling Holiday Resorts launches new property in Lonavala

Sebi specifies checks for AIFs to curb circumvention and ever-greening

Quick Wrap: Nifty Media Index rises 3.11%

Garuda Construction and Engg IPO subscribed 1.91 times

LTIMindtree launches Smart Spaces solution with its digital transformation platform iNXT

Markets rally as BJP wins Haryana; Nifty crosses 25,000, metal stocks drag

Tata Motors Group global wholesales decline 11% in Q2 FY25

Maruti Suzuki launches Grand Vitara Dominion Limited Edition